Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger: https://m.media-amazon.com/images/I/81C-4G2rN2L._AC_SL1500_.jpg
Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger
Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger Jetzt ansehen Du bist auf der Suche nach einem vielseitigen Objektiv, das dich auf deinen
Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger: https://m.media-amazon.com/images/I/81C-4G2rN2L._AC_SL1500_.jpg
Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger
Schnapp dir den ultimativen Allrounder: Olympus M.Zuiko Digital ED 12-200mm F3.5-6.3 jetzt 16% günstiger Jetzt ansehen Du bist auf der Suche nach einem vielseitigen Objektiv, das dich auf deinen
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)
DGAP-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2021 (IFRS)